CAIHF (CPBIO Holding Co) Buyback Yield %: 0.00 (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAIHF CPBIO Holding Co Ltd CAIHF
71 GF Score
Price $0.28
GF Value $0.14
! 4 Warning Signs
View Full Analysis

What is CPBIO Holding Co Buyback Yield %?

CPBIO Holding Co CAIHF 71 Buyback Yield % is 0.00 as of Aug. 06, 2026. GuruFocus rates CAIHF with a GF Score™ of 71/100 and a GF Value™ of $0.14. The stock has 4 warning signs investors should review. Among 276 Drug Manufacturers companies, CPBIO Holding Co ranks worse than 362318.48% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

CPBIO Holding Co's current buyback yield was 0.00%.


CPBIO Holding Co Buyback Yield % Historical Data

* Premium members only.

The historical data trend for CPBIO Holding Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CPBIO Holding Co Buyback Yield % Chart

CPBIO Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CPBIO Holding Co Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CAIHF vs ZTS: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CPBIO Holding Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CPBIO Holding Co Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CPBIO Holding Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where CPBIO Holding Co's Buyback Yield % falls into.


CAIHF
71GF Score
CPBIO Holding Co Ltd CAIHF
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CPBIO Holding Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

CPBIO Holding Co's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 67.40104
=0.00%

CPBIO Holding Co's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 67.40104
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
CPBIO Holding Co (CAIHF) has a Buyback Yield % of 0.00 as of Aug. 06, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CPBIO Holding Co and its competitors. According to the industry distribution chart, CPBIO Holding Co ranks #999999 out of 276 companies in the Drug Manufacturers industry.
Is CPBIO Holding Co's Buyback Yield % too high?
CPBIO Holding Co's current Buyback Yield % is 0.00. Based on the distribution chart, CPBIO Holding Co ranks #999999 out of 276 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, CPBIO Holding Co has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does CPBIO Holding Co's Buyback Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, CPBIO Holding Co ranks #999999 out of 276 companies for Buyback Yield %. This places CPBIO Holding Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CPBIO Holding Co and its competitors. CPBIO Holding Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CPBIO Holding Co stock overvalued right now?
CPBIO Holding Co (CAIHF) has a current Buyback Yield % of 0.00. The stock's GF Value™ is $0.14, compared to a current price of $0.28 — trading 100% above its estimated fair value. The current Buyback Yield % is 0.00. CPBIO Holding Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For CPBIO Holding Co (CAIHF), the current Buyback Yield % is 0.00 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CPBIO Holding Co (CAIHF) Overvalued in 2026?

Based on GuruFocus' analysis, CPBIO Holding Co stock appears to be overvalued. The current stock price of $0.28 is trading 100% above its estimated GF Value™ of $0.14.

Key valuation signals for CAIHF:

  • Buyback Yield %: 0.00
  • GF Value™: $0.14 vs. price of $0.28 (100% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the CAIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CPBIO Holding Co Business Description

Other Exchanges 03839:Hong Kong
Address 16 Harcourt Road, 21st Floor, Far East Finance Centre, Central, Hong Kong, HKG
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of animal health products and chlortetracycline (CTC). The group has two reportable segments: Biotech Business and Investment Business. The Biotech Business segment is involved in the manufacture and/or sale of animal health products and chlortetracycline. The Investment Business segment is engaged in the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. It generates the majority of its revenue from the Biotech Business segment. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.
71GF Score

Get the complete analysis for CAIHF

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price
$0.14
GF Value